Np mrd loader

Record Information
Version2.0
Created at2006-10-17 08:50:19 UTC
Updated at2024-09-17 15:42:12 UTC
NP-MRD IDNP0000546
Secondary Accession NumbersNone
Natural Product Identification
Common NameAmlodipine
DescriptionAmlodipine is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell; A long acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension; in angina it improves blood flow to the myocardium. Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell.
Structure
Thumb
Synonyms
ValueSource
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylateChEBI
Amlodipine free baseChEBI
AmlodipinoChEBI
AmlodipinumChEBI
NorvascKegg
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acidGenerator
Amlodipine besilateHMDB
Amlodipine besylateHMDB
AMVAZHMDB
IstinHMDB
PelmecHMDB
Racemic amlodipineHMDB
Amlodipine, (+-)-isomerHMDB
Amlodipine, (+-)-isomer, maleate (1:1)HMDB
Amlodipine, (S)-isomer, maleate (1:1)HMDB
AmlorHMDB
Amlodipine, (R)-isomerHMDB
Pfizer brand OF amlodipine besilateHMDB
Amlodipine maleateHMDB
Amlodipine maleate (1:1)HMDB
AmlodisHMDB
AstudalHMDB
Mack brand OF amlodipine besilateHMDB
Almirall brand OF amlodipine besilateHMDB
Eczacibasi brand OF amlodipine besilateHMDB
Chemical FormulaC20H25ClN2O5
Average Mass408.8760 Da
Monoisotopic Mass408.14520 Da
IUPAC Name3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Traditional Name(+-)-amlodipine
CAS Registry Number88150-42-9
SMILES
CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC
InChI Identifier
InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3
InChI KeyHTIQEAQVCYTUBX-UHFFFAOYSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
2D NMR[1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, D2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
  • Animalia
  • Chemical Taxonomy
    Description Belongs to the class of organic compounds known as dihydropyridinecarboxylic acids and derivatives. Dihydropyridinecarboxylic acids and derivatives are compounds containing a dihydropyridine moiety bearing a carboxylic acid group.
    KingdomOrganic compounds
    Super ClassOrganoheterocyclic compounds
    ClassPyridines and derivatives
    Sub ClassHydropyridines
    Direct ParentDihydropyridinecarboxylic acids and derivatives
    Alternative Parents
    Substituents
    • Dihydropyridinecarboxylic acid derivative
    • Chlorobenzene
    • Halobenzene
    • Aryl chloride
    • Aryl halide
    • Monocyclic benzene moiety
    • Dicarboxylic acid or derivatives
    • Benzenoid
    • Vinylogous amide
    • Alpha,beta-unsaturated carboxylic ester
    • Enoate ester
    • Methyl ester
    • Amino acid or derivatives
    • Carboxylic acid ester
    • Carboxylic acid derivative
    • Dialkyl ether
    • Secondary aliphatic amine
    • Azacycle
    • Enamine
    • Ether
    • Secondary amine
    • Organic nitrogen compound
    • Hydrocarbon derivative
    • Organooxygen compound
    • Organic oxide
    • Amine
    • Primary amine
    • Organic oxygen compound
    • Organopnictogen compound
    • Carbonyl group
    • Primary aliphatic amine
    • Organohalogen compound
    • Organochloride
    • Organonitrogen compound
    • Aromatic heteromonocyclic compound
    Molecular FrameworkAromatic heteromonocyclic compounds
    External Descriptors
    Physical Properties
    StateSolid
    Experimental Properties
    PropertyValueReference
    Melting PointNot AvailableNot Available
    Boiling PointNot AvailableNot Available
    Water SolubilityNot AvailableNot Available
    LogP3.00Austin, R. P., Davis, A. M., & Manners, C. N. (1995). Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles. Journal of pharmaceutical sciences, 84(10), 1180-1183.
    Predicted Properties
    PropertyValueSource
    Water Solubility0.0074 g/LALOGPS
    logP2.22ALOGPS
    logP1.64ChemAxon
    logS-4.7ALOGPS
    pKa (Strongest Acidic)19.12ChemAxon
    pKa (Strongest Basic)9.45ChemAxon
    Physiological Charge1ChemAxon
    Hydrogen Acceptor Count5ChemAxon
    Hydrogen Donor Count2ChemAxon
    Polar Surface Area99.88 ŲChemAxon
    Rotatable Bond Count10ChemAxon
    Refractivity108.64 m³·mol⁻¹ChemAxon
    Polarizability42.31 ųChemAxon
    Number of Rings2ChemAxon
    BioavailabilityYesChemAxon
    Rule of FiveYesChemAxon
    Ghose FilterYesChemAxon
    Veber's RuleNoChemAxon
    MDDR-like RuleNoChemAxon
    HMDB IDHMDB0005018
    DrugBank IDDB00381
    Phenol Explorer Compound IDNot Available
    FoodDB IDFDB023590
    KNApSAcK IDNot Available
    Chemspider ID2077
    KEGG Compound IDC06825
    BioCyc IDNot Available
    BiGG IDNot Available
    Wikipedia LinkAmlodipine
    METLIN ID955
    PubChem Compound2162
    PDB IDNot Available
    ChEBI ID2668
    Good Scents IDNot Available
    References
    General References
    1. Iabichella ML, Dell'Omo G, Melillo E, Pedrinelli R: Calcium channel blockers blunt postural cutaneous vasoconstriction in hypertensive patients. Hypertension. 1997 Mar;29(3):751-6. [PubMed:9052891 ]
    2. Pedrinelli R, Dell'Omo G, Nuti M, Menegato A, Balbarini A, Mariani M: Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens. 2003 Oct;21(10):1969-73. [PubMed:14508205 ]
    3. Meredith PA, Elliott HL: Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 1992 Jan;22(1):22-31. doi: 10.2165/00003088-199222010-00003. [PubMed:1532771 ]
    4. Pascual J: Hypertension control in the elderly with amlodipine. Curr Med Res Opin. 2000;16(1):33-6. doi: 10.1185/0300799009117005. [PubMed:16422032 ]
    5. Burges RA: Amlodipine: a once daily calcium antagonist. J Hum Hypertens. 1991 Aug;5 Suppl 1:49-54. [PubMed:1834846 ]